J Mov Disord.  2021 May;14(2):157-160. 10.14802/jmd.20159.

Dystonia Responsive to Dopamine: POLG Mutations Should Be Considered If Sensory Neuropathy Is Present

Affiliations
  • 1Department of Neurology, Concord Repatriation General Hospital, Sydney, Australia
  • 2Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, Australia
  • 3Department of Neurogenetics, Kolling Institute, University of Sydney and Royal North Shore Hospital, St Leonards, Australia
  • 4Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, Australia
  • 5Molecular Medicine Laboratory, Concord Repatriation General Hospital, Sydney, Australia

Abstract

The POLG gene encodes mitochondrial DNA polymerase, and mutations in this gene cause a spectrum of disorders related to mitochondrial DNA depletion or deletion. Dystonia has only rarely been reported as an early and prominent manifestation of POLG mutations. We report a case of a 30-year-old male presenting with lower limb dystonia with peripheral neuropathy and demonstrate that the dystonia was levodopa responsive (with video findings). Whole-genome sequencing revealed biallelic variants in the POLG gene: a known pathogenic variant [NM_001126131.2:c.2209G>C (p.Gly737Arg)] and a novel likely pathogenic variant [NM_001126131.2:c.3305A>C (p.Gln1102Pro)]. A genetic diagnosis was made before the appearance of more readily recognizable features of mitochondrial disease, allowing us to avoid invasive tissue biopsies or potentially deleterious treatments, such as sodium valproate. A POLG-related disorder should be suspected in cases of dystonia with peripheral neuropathy, and this diagnosis may have implications for further investigations and management.

Keyword

Dystonia; Genetics; Peripheral Neuropathies; Parkinsonism; POLG
Full Text Links
  • JMD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr